Summary by Futu AI
Tengshengbo Pharmaceutical Bio-Technology Co., Ltd. ('Tengshengbo Medicine-B') announced that the board of directors will hold a meeting on August 19, 2024 (Monday) to review and approve the unaudited interim performance report for the six months ended June 30, 2024. The meeting will be chaired by Dr. Zhi Hong, chairman of the board of directors, and other matters will be dealt with. Board members include executive directors Dr. Zhi Hong and Dr. Li An Kang, as well as independent non-executive directors Dr. Martin J Murphy Jr., Ms. Grace Hui Tang, Mr. Xu Yaohua, Mr. Gregg Huber Alton and Dr. Yang Taiying.